JP2011507859A5 - - Google Patents

Download PDF

Info

Publication number
JP2011507859A5
JP2011507859A5 JP2010539516A JP2010539516A JP2011507859A5 JP 2011507859 A5 JP2011507859 A5 JP 2011507859A5 JP 2010539516 A JP2010539516 A JP 2010539516A JP 2010539516 A JP2010539516 A JP 2010539516A JP 2011507859 A5 JP2011507859 A5 JP 2011507859A5
Authority
JP
Japan
Prior art keywords
connexin
composition
polynucleotide
oligonucleotide
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010539516A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011507859A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/014024 external-priority patent/WO2009085273A2/en
Publication of JP2011507859A publication Critical patent/JP2011507859A/ja
Publication of JP2011507859A5 publication Critical patent/JP2011507859A5/ja
Pending legal-status Critical Current

Links

JP2010539516A 2007-12-21 2008-12-22 外科的癒着の治療のための抗コネキシンポリヌクレオチドの使用 Pending JP2011507859A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US874807P 2007-12-21 2007-12-21
PCT/US2008/014024 WO2009085273A2 (en) 2007-12-21 2008-12-22 Use of anti-connexin polynucleotides for the treatment of surgical adhesions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014173528A Division JP2015013880A (ja) 2007-12-21 2014-08-28 外科的癒着の治療のための抗コネキシンポリヌクレオチドの使用

Publications (2)

Publication Number Publication Date
JP2011507859A JP2011507859A (ja) 2011-03-10
JP2011507859A5 true JP2011507859A5 (enExample) 2013-04-25

Family

ID=40824957

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010539516A Pending JP2011507859A (ja) 2007-12-21 2008-12-22 外科的癒着の治療のための抗コネキシンポリヌクレオチドの使用
JP2014173528A Pending JP2015013880A (ja) 2007-12-21 2014-08-28 外科的癒着の治療のための抗コネキシンポリヌクレオチドの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014173528A Pending JP2015013880A (ja) 2007-12-21 2014-08-28 外科的癒着の治療のための抗コネキシンポリヌクレオチドの使用

Country Status (7)

Country Link
US (1) US20110144182A1 (enExample)
EP (1) EP2252689A2 (enExample)
JP (2) JP2011507859A (enExample)
AU (1) AU2008343754A1 (enExample)
CA (1) CA2710227A1 (enExample)
WO (1) WO2009085273A2 (enExample)
ZA (1) ZA201005220B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2662088A3 (en) 2005-02-03 2014-02-19 Coda Therapeutics Limited Anti-connexin compounds and uses thereof
US8975237B2 (en) 2007-12-21 2015-03-10 Coda Therapeutics, Inc. Treatment of fibrotic conditions
JP6075732B2 (ja) * 2010-04-13 2017-02-08 ケーシーアイ ライセンシング インク 反応性成分を含む組成物ならびに創傷被覆材、装置および方法
CN104271142B (zh) 2012-03-01 2017-07-04 福斯特斯特林研究公司 含有α连接蛋白C‑末端(ACT)肽的局部凝胶
CN104736709A (zh) 2012-03-27 2015-06-24 科达治疗公司 基于钙粘蛋白调节的组合物和治疗
WO2013151910A1 (en) * 2012-04-02 2013-10-10 Saint Louis University Methods and compositions for reducing the incidence of post-surgical adhesions
JP6683686B2 (ja) 2014-08-22 2020-04-22 オークランド ユニサービシーズ リミティド チャネル調節剤
WO2018199777A1 (en) 2017-04-28 2018-11-01 Auckland Uniservices Limited Methods of treatment and novel constructs
EP4232157A4 (en) 2020-10-22 2024-08-28 Xequel Bio, Inc. PEPTIDE FORMULATIONS AND ASSOCIATED OPHTHALMIC USES

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687808A (en) * 1969-08-14 1972-08-29 Univ Leland Stanford Junior Synthetic polynucleotides
US5034506A (en) * 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
CA1322714C (en) * 1986-11-14 1993-10-05 Harry N. Antoniades Wound healing and bone regeneration
JPH0539594Y2 (enExample) * 1988-08-05 1993-10-07
US5166195A (en) * 1990-05-11 1992-11-24 Isis Pharmaceuticals, Inc. Antisense inhibitors of the human immunodeficiency virus phosphorothioate oligonucleotides
US20030148968A1 (en) * 1995-02-28 2003-08-07 Hammond H. Kirk Techniques and compositions for treating cardiovascular disease by in vivo gene delivery
US6752987B1 (en) * 1995-02-28 2004-06-22 The Regents Of The University Of California Adenovirus encoding human adenylylcyclase (AC) VI
WO1999007844A2 (en) * 1997-08-07 1999-02-18 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Methods and compositions for treatment of restenosis
EP1037981A1 (en) * 1997-12-09 2000-09-27 Children's Medical Center Corporation Soluble inhibitors of vascular endothelial growth factor and use thereof
US6506559B1 (en) * 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
CA2361251C (en) * 1999-01-27 2011-03-08 David L. Becker Formulations comprising antisense nucleotides to connexins
US5998148A (en) * 1999-04-08 1999-12-07 Isis Pharmaceuticals Inc. Antisense modulation of microtubule-associated protein 4 expression
US20060105013A1 (en) * 2000-10-18 2006-05-18 Samy Ashkar Osteopontin-coated surfaces and methods of use
US20050119211A1 (en) * 2001-05-18 2005-06-02 Sirna Therapeutics, Inc. RNA mediated inhibition connexin gene expression using short interfering nucleic acid (siNA)
JP2005509621A (ja) * 2001-10-17 2005-04-14 ユニバーシティ オブ ウェールズ カレッジ オブ メディスン ギャップ結合ならびにｅｄｈｆ
CN1939529A (zh) * 2002-01-29 2007-04-04 Wyeth公司 用于调节连接蛋白半通道的组合物和方法
US20030215424A1 (en) * 2002-05-15 2003-11-20 Seul Kyung Hwan Method of modulating angiogenesis
US8809504B2 (en) * 2002-09-03 2014-08-19 Vit Lauermann Inhibitor which is deactivatable by a reagent produced by a target cell
WO2006006948A2 (en) * 2002-11-14 2006-01-19 Dharmacon, Inc. METHODS AND COMPOSITIONS FOR SELECTING siRNA OF IMPROVED FUNCTIONALITY
JP5838017B2 (ja) * 2003-12-03 2015-12-24 コーダ セラピューティクス， インコーポレイテッド コネキシンに対して標的化されたアンチセンス化合物およびその使用方法
WO2006032143A1 (en) * 2004-09-23 2006-03-30 Arc Pharmaceuticals, Inc. Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans
EP2662088A3 (en) * 2005-02-03 2014-02-19 Coda Therapeutics Limited Anti-connexin compounds and uses thereof
EA200870058A1 (ru) * 2005-12-16 2008-12-30 Арла Фудс Амба Композиции, содержащие остеопонтин крупного рогатого скота, для улучшения процесса заживления ран
US8323968B2 (en) * 2007-03-02 2012-12-04 National University Of Ireland, Galway Osteopontin for the prediction and treatment of cardiovascular diseases
AU2008335718A1 (en) * 2007-12-11 2009-06-18 Coda Therapeutics, Inc. Impaired wound healing compositions and treatments

Similar Documents

Publication Publication Date Title
JP5607176B2 (ja) 新規ペプチドおよびその用途
US8668703B2 (en) Medical devices incorporating collagen inhibitors
US20090180965A1 (en) Methods for repair and regeneration of bone marrow
CN107105749A (zh) 抗微生物化合物和组合物及其用途
JP4307561B2 (ja) 創傷の治癒
JP2011507858A5 (enExample)
US9782522B2 (en) Compositions and methods for treating and preventing neointimal stenosis
KR20120014251A (ko) 동종이식편의 접합을 개선하기 위한 생체활성 코팅 조성물 및 방법
JP2011507599A5 (enExample)
JP2011507855A5 (enExample)
Hildebrand et al. Joint capsule matrix turnover in a rabbit model of chronic joint contractures: correlation with human contractures
CN105078889B (zh) 一种用于治疗软骨疾病的脂质体递送系统及其制备方法
DE602005025347D1 (de) Oligoribonukleotide und verfahren zu deren anwendung bei der behandlung von fibrotischen leiden und anderen krankheiten
JP2018521669A (ja) 治療用オリゴヌクレオチド
WO2013059879A1 (en) Compositions and methods for the treatment of fibrosis and fibrotic diseases
JP7129399B2 (ja) 哺乳動物における滑膜炎の予防および／または治療に使用するためのポリアクリルアミドヒドロゲル
CN107617106A (zh) 一种血管紧张素转换酶类抗瘢痕制剂
TW201023879A (en) Method of inhibiting and/or rescuing cell terminal differentiation, and composition for treating and/or inhibiting arthritis
JP7514563B2 (ja) オルガノイドおよび抗炎症剤を含む炎症性腸疾患の予防または治療用薬学組成物
RU2425669C1 (ru) Средство для профилактики и лечения острого и хронического панкреатита
US20180214388A1 (en) Composition and method for reducing scarring
JP2024508333A (ja) カテニンｍＲＮＡを含む組成物および骨折を治すためのその使用
Meisel et al. Sunitinib inhibits postoperative adhesions in a rabbit model
CN102089008A (zh) 用于骨骼再生的胶原凝胶组合物的制备方法
CN104644620B (zh) 化合物xl‑001在制备治疗慢性肾脏病的药物中的用途